2m 2m 2m 2m 2m 2m 2m
GUARDIAN-A (GRDN)
NYSE
$40.10+$0.91 (+2.32%)
Price as of Jun 23, 2026 7:57 PM EDT- $2.1BMarket Cap
- 90.24%1-Year Change
- Medical Care FacilitiesIndustry
GUARDIAN-A (GRDN)
$40.10+$0.91 (+2.32%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | ||
|---|---|---|---|
Income Statement | |||
Total Operating Revenue | 1.4B +17.93% | 1.2B N/A | |
Cost of Revenue | 1.2B +17.47% | 984.0M N/A | |
Gross Profit | 292.7M +19.78% | 244.4M N/A | |
Sales and Marketing Expense | 220.0M -28.40% | 307.3M N/A | |
Research and Development Expense | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 22.3M +12.96% | 19.8M N/A | |
Total Operating Expenses | 1.2B +17.47% | 984.0M N/A | |
Operating Profit | 72.7M +215.55% | -62.9M N/A | |
Interest Income | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 722,000 +120.30% | -3.6M N/A | |
Income before Taxes | 73.4M +210.45% | -66.5M N/A | |
Income Taxes | 24.5M +436.98% | 4.6M N/A | |
Extraordinary Items | N/A N/A | N/A N/A | |
Net Income | 49.2M +144.73% | -110.0M N/A | |
Net Income from Continuing Operations Applicable to Common | 73.4M +210.45% | -66.5M N/A | |
Basic EPS and Net Income | 0.79 +144.63% | -1.77 N/A | |
Diluted EPS and Net Income | 0.78 +144.07% | -1.77 N/A | |
Basic Weighted Average Shares | 62.4M +0.61% | 62.0M N/A | |
Diluted Weighted Average Shares | 63.3M +2.08% | 62.0M N/A | |
Balance Sheet | |||
Cash and Cash Equivalents | 65.6M +1,308.13% | 4.7M N/A | |
Short-Term Investments | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 65.6M +1,308.13% | 4.7M N/A | |
Total Current Assets | 221.6M +45.83% | 152.0M N/A | |
Accumulated Depreciation | 87.8M +12.65% | 78.0M N/A | |
Property and Plant and Equipment and Net | 55.5M +11.30% | 49.9M N/A | |
Total Long-Term Assets | 436,000 +13.84% | 383,000 N/A | |
Total Assets | 412.7M +28.63% | 320.8M N/A | |
Income Taxes Payable | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | 13.0M N/A | |
Total Current Liabilities | 160.7M +11.51% | 144.1M N/A | |
Total Long-Term Debt | 0 -100.00% | 19.0M N/A | |
Total Long-Term Liabilities | 4.0M +18.24% | 3.4M N/A | |
Total Liabilities | 194.7M +13.99% | 170.8M N/A | |
Retained Earnings | 66.3M +287.43% | 17.1M N/A | |
Total Stockholders Equity | 217.9M +672.53% | 28.2M N/A | |
Total Shares Outstanding | 36.3M +294.06% | 9.2M N/A | |
Cash Flow | |||
Cash from Operating Activities | 100.3M +72.97% | 58.0M N/A | |
Capital Expenditures | 13.4M -8.80% | 14.7M N/A | |
Cash from Investing Activities | -32.2M +5.98% | -30.4M N/A | |
Dividends Paid | N/A N/A | N/A N/A | |
Cash from Financing Activities | -7.1M -70.10% | -23.6M N/A | |
Financials Ratio | |||
Gross Margin | 20.21% N/A | N/A N/A | |
Operating Margin | 5.02% N/A | N/A N/A | |
Return on Assets | 13.42% N/A | N/A N/A | |
Return on Equity | 39.99% N/A | N/A N/A | |
Revenue Growth | 17.93% N/A | N/A N/A | |
Current Ratio | 1.38 N/A | N/A N/A | |
Cash Ratio | 0.41 N/A | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow